Related references
Note: Only part of the references are listed.Engineered off-the-shelf therapeutic T cells resist host immune rejection
Feiyan Mo et al.
NATURE BIOTECHNOLOGY (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
Huang Zhu et al.
BLOOD (2020)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells
Seiji Nagano et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy
Yuki Kagoya et al.
CANCER IMMUNOLOGY RESEARCH (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
T cells, aging and senescence
Luca Pangrazzi et al.
EXPERIMENTAL GERONTOLOGY (2020)
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey et al.
NATURE MEDICINE (2020)
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
Reuben Benjamin et al.
LANCET (2020)
Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
Huaigeng Xu et al.
CELL STEM CELL (2019)
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
Tobias Deuse et al.
NATURE BIOTECHNOLOGY (2019)
Allogenic V9V2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
Mohammed Alnaggar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
John K. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges
Alexandros Nianias et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma
Ryan Bjordahl et al.
BLOOD (2019)
FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial
Chiawei Chang et al.
BLOOD (2019)
FT538: Preclinical Development of an Off-the-Shelf Adoptive NK Cell Immunotherapy with Targeted Disruption of CD38 to Prevent Anti-CD38 Antibody-Mediated Fratricide and Enhance ADCC in Multiple Myeloma When Combined with Daratumumab
Ryan Bjordahl et al.
BLOOD (2019)
FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies
Jode P. Goodridge et al.
BLOOD (2019)
Harnessing NK Cells for Cancer Treatment
Paola Minetto et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
New Insights into Graft-Versus-Host Disease and Graft Rejection
Eric Perkey et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy
Jillian Rosenberg et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2018)
A novel method to generate T-cell receptor deficient chimeric antigen receptor T cells
Takahiro Kamiya et al.
BLOOD ADVANCES (2018)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes
Miki Ando et al.
EXPERIMENTAL HEMATOLOGY (2017)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
German G. Gornalusse et al.
NATURE BIOTECHNOLOGY (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse
Daniel J. Firl et al.
FRONTIERS IN IMMUNOLOGY (2017)
Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors
Hiroki Torikai et al.
MOLECULAR THERAPY (2016)
Allorecognition by T Lymphocytes and Allograft Rejection
Jose Marino et al.
FRONTIERS IN IMMUNOLOGY (2016)
Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments
Mateja Kralj Juric et al.
FRONTIERS IN IMMUNOLOGY (2016)
Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
Justyna Ogonek et al.
FRONTIERS IN IMMUNOLOGY (2016)
Multiplex Genome-Edited T-cell Manufacturing Platform for Off-the-Shelf Adoptive T-cell Immunotherapies
Laurent Poirot et al.
CANCER RESEARCH (2015)
Immune reconstitution following stem cell transplantation
Marcel R. M. van den Brink et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey et al.
BLOOD (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
NK cell self tolerance, responsiveness and missing self recognition
Nataliya Shifrin et al.
SEMINARS IN IMMUNOLOGY (2014)
The TNF family in T cell differentiation and function - Unanswered questions and future directions
Michael Croft
SEMINARS IN IMMUNOLOGY (2014)
Improving the safety of cell therapy products by suicide gene transfer
Benjamin S. Jones et al.
Frontiers in Pharmacology (2014)
The impact of ageing on natural killer cell function and potential consequences for health in older adults
Jon Hazeldine et al.
AGEING RESEARCH REVIEWS (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Hiroki Torikai et al.
BLOOD (2013)
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
Maria Themeli et al.
NATURE BIOTECHNOLOGY (2013)
Origin and Biology of the Allogeneic Response
Fadi G. Lakkis et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Hiroki Torikai et al.
BLOOD (2012)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia
Andrea Velardi et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Natural killer cell recognition of missing self
Klas Karre
NATURE IMMUNOLOGY (2008)
Specificity of T-cell alloreactivity
Nathan J. Felix et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Missing self recognition and self tolerance of natural killer (NK) cells
David H. Raulet
SEMINARS IN IMMUNOLOGY (2006)
The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B
LD Lieto et al.
GENES AND IMMUNITY (2006)
Minors come of age: Minor histocompatibility antigens and graft-versus-host disease
NJ Chao
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA
M Krawczyk et al.
JOURNAL OF IMMUNOLOGY (2004)
Minor histocompatibility antigens in human stem cell transplantation
JHF Falkenburg et al.
EXPERIMENTAL HEMATOLOGY (2003)
Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?
M Croft
NATURE REVIEWS IMMUNOLOGY (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III
TM Holling et al.
JOURNAL OF IMMUNOLOGY (2002)
Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias
MW Lowdell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Integrin-associated protein (CD47) and its ligands
EJ Brown et al.
TRENDS IN CELL BIOLOGY (2001)
Share Paper
